Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7799331 | TARO | Oral suspension of prednisolone acetate |
Oct, 2028
(5 years from now) |
Drugs and Companies using PREDNISOLONE ACETATE ingredient
Market Authorisation Date: 17 January, 2008
Treatment: Treatment of asthma; Treatment of allergic reactions
Dosage: SUSPENSION;ORAL
6
United States
2
Japan
2
European Union
1
Canada
1
China
1
South Africa
1
Australia
1
New Zealand
1
Korea, Republic of
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic